• IOL Chemicals gets renewal of “HALAL CERTIFICATE’
IOL Chemicals & Pharmaceuticals Ltd has informed that the Company has got renewal of “HALAL CERTIFICATE’ from Hold Committee, Jamiat Ulama - E - Maharashtra for Ibuprofen, iso Buty / Benezene, Ethyl Acetate and other products of the Company for the year 2015-2016. It will facilitate the Company to explore the untapped export markets for its products.
• Relaxo Footwears touches fresh high on ex-bonus
Shares of Relaxo Footwears rose 4% at Rs493, also their record high on the BSE. Today, the stock turned ex- bonus in the ratio of 1:1.The board of directors of the footwear company at its meeting held on May 11, 2015, had recommended the issue of bonus shares in the ratio of 1:1 i.e. one equity share for every one equity share held. Since then, the stock has outperformed the market by gaining 38% on BSE.
• JSW Energy plans to raise Rs12,500 cr for capex, expansion
JSW Energy is planning to raise up to Rs12,500 crore through issuance of various securities as it eyes organic and inorganic ways to expand business. The firm will seek shareholders' approval next month for raising up to Rs5,000 crore for ongoing capital expenditure and another Rs7,500 crore to pursue 'organic and inorganic growth opportunities'
• Puravankara jumps after company monetise its land
Puravankara Projects rose over 10%, touching to Rs87.75, after the company has monetised its land in Bengaluru. Puravankara has entered into an agreement to sell for its 18 acre property located off Kanakapura Road, Bengaluru,' said the company. This is a strategic transaction and coincides with our business and capital strategy of the group, it added.
• BASF receives Rs144 cr from sales of textile business
BASF receives Rs144 cr from sales of textile business – Positive read thru .BASF India Ltd has now informed that the said closing has taken place and consequently, with effect from July 01, 2015, the textile chemicals business of the Company will stand transferred to Archroma India Private Limited on a 'going concern basis'.
No comments:
Post a Comment